ArticleCancer reports (Hoboken, N.J.)2026

Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report.

Li Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.